• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PKD1 功能减弱等位基因影响常染色体显性遗传性多囊肾病的疾病变异性。

Hypomorphic PKD1 Alleles Impact Disease Variability in Autosomal Dominant Polycystic Kidney Disease.

机构信息

Division of Nephrology, Children's National Hospital, Washington, District of Columbia.

Children's National Research Institute, Washington, District of Columbia.

出版信息

Kidney360. 2023 Mar 1;4(3):387-392. doi: 10.34067/KID.0000000000000064.

DOI:10.34067/KID.0000000000000064
PMID:36706243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10103195/
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) manifesting earlier than expected on the basis of family history can identify clinically tolerant alleles with reduced expression. Hypomorphic alleles can cause mild kidney disease or liver cysts in the absence of clinically manifest kidney involvement. The presented data highlight pleiotropic ADPKD clinical presentations and varying severity of kidney disease from allele combinations.

摘要

常染色体显性多囊肾病 (ADPKD) 基于家族史表现出早于预期的情况,可以鉴定出临床上耐受的表达降低的等位基因。低功能等位基因可导致轻度肾脏疾病或肝脏囊肿,而无临床明显的肾脏受累。所呈现的数据突出了 ADPKD 的多种临床表现和不同严重程度的肾脏疾病与等位基因组合有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185f/10103195/aee951eee200/kidney360-4-387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185f/10103195/3d9b67edb496/kidney360-4-387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185f/10103195/aee951eee200/kidney360-4-387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185f/10103195/3d9b67edb496/kidney360-4-387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185f/10103195/aee951eee200/kidney360-4-387-g002.jpg

相似文献

1
Hypomorphic PKD1 Alleles Impact Disease Variability in Autosomal Dominant Polycystic Kidney Disease.PKD1 功能减弱等位基因影响常染色体显性遗传性多囊肾病的疾病变异性。
Kidney360. 2023 Mar 1;4(3):387-392. doi: 10.34067/KID.0000000000000064.
2
Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.家族性常染色体显性多囊肾病伴镶嵌现象和低功能等位基因。
BMC Nephrol. 2013 Mar 15;14:59. doi: 10.1186/1471-2369-14-59.
3
Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of Hypomorphic Alleles.常染色体显性遗传多囊肾病严重程度的修饰因子:低功能等位基因的作用。
Genes (Basel). 2023 Jun 7;14(6):1230. doi: 10.3390/genes14061230.
4
Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families.双等位基因 PKD1 突变导致沙特阿拉伯家族性常染色体显性遗传性多囊肾病的早发。
Pediatr Nephrol. 2019 Sep;34(9):1615-1623. doi: 10.1007/s00467-019-04267-x. Epub 2019 May 11.
5
A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.一种新的PKD1变异体在常染色体显性遗传性多囊肾病患者中与截短型PKD1突变呈反式作用,表现出疾病修饰作用。
BMC Nephrol. 2015 Mar 1;16:26. doi: 10.1186/s12882-015-0015-7.
6
Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease.常染色体显性和常染色体隐性多囊肾病的基因型-表型相关性
J Am Soc Nephrol. 2007 May;18(5):1374-80. doi: 10.1681/ASN.2007010125. Epub 2007 Apr 11.
7
A study of sirolimus and mTOR kinase inhibitor in a hypomorphic mouse model of autosomal dominant polycystic kidney disease.西罗莫司和mTOR激酶抑制剂在常染色体显性多囊肾病低表达小鼠模型中的研究。
Am J Physiol Renal Physiol. 2019 Jul 1;317(1):F187-F196. doi: 10.1152/ajprenal.00051.2019. Epub 2019 May 1.
8
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.单等位基因 IFT140 致病性变异是常染色体显性多囊肾病谱表型的一个重要原因。
Am J Hum Genet. 2022 Jan 6;109(1):136-156. doi: 10.1016/j.ajhg.2021.11.016. Epub 2021 Dec 9.
9
Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.常染色体显性多囊肾病分子遗传学的当前进展
Curr Opin Nephrol Hypertens. 2001 Jan;10(1):23-31. doi: 10.1097/00041552-200101000-00005.
10
Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.通过全外显子组测序鉴定和分析沙特患者慢性肾脏病(CKD)和常染色体显性多囊肾病(ADPKD)中的新型突变。
Medicina (Kaunas). 2022 Nov 16;58(11):1657. doi: 10.3390/medicina58111657.

引用本文的文献

1
Using large-scale population-based data to improve disease risk assessment of clinical variants.利用基于大规模人群的数据改进临床变异的疾病风险评估。
Nat Genet. 2025 Jun 23. doi: 10.1038/s41588-025-02212-3.
2
Chaperones as Potential Pharmacological Targets for Treating Protein Aggregation Illness.伴侣蛋白作为治疗蛋白质聚集疾病的潜在药理学靶点
Curr Protein Pept Sci. 2025 Jan 27. doi: 10.2174/0113892037338028241230092414.
3
Defining Risk in APOL1-Associated Kidney Disease: The Story is Evolving!定义APOL1相关肾病的风险:故事仍在演变!
Am J Kidney Dis. 2024 Sep;84(3):388-391. doi: 10.1053/j.ajkd.2024.03.016. Epub 2024 Apr 20.
4
Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of Hypomorphic Alleles.常染色体显性遗传多囊肾病严重程度的修饰因子:低功能等位基因的作用。
Genes (Basel). 2023 Jun 7;14(6):1230. doi: 10.3390/genes14061230.